KATHLEEN MEHALL: Open Payments
NPI 1689802415 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,223 in 125 payments from 19 companies in 2025. Trend: 2023 $1,538 · 2024 $2,510 · 2025 $2,223
Food & beverage: $2,216Education: $7
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $378 |
| GENZYME CORPORATION | 12 | $316 |
| Regeneron Healthcare Solutions, Inc. | 9 | $212 |
| Galderma Laboratories, L.P. | 15 | $176 |
| UCB, Inc. | 10 | $174 |
| Novartis Pharmaceuticals Corporation | 10 | $160 |
| ABBVIE INC. | 12 | $158 |
| Biofrontera Inc. | 5 | $100 |
| Lilly USA, LLC | 4 | $86 |
| Amgen Inc. | 4 | $71 |
Products named: DUPIXENT, TREMFYA, Bimzelx, NEMLUVIO, AXERT, SKYRIZI, COSENTYX, OTEZLA.
Industry payments across PA — which companies pay providers there.
